In the news.
FDA approves first engineered T-cell therapy for solid tumor
The FDA approved an engineered T-cell therapy, called a T-cell receptor (TCR) therapy, to treat synovial sarcoma.
Read More
FDA approves first engineered T-cell therapy for solid tumor
The FDA approved an engineered T-cell therapy, called a T-cell receptor (TCR) therapy, to treat synovial sarcoma.
Read More
Celebrating Laurie Adami’s CAR T-cell anniversary
July 16 has more than one significance for Laurie Adami. It’s the date she met her future husband and the date cancer cell and gene therapy saved her life.
Read More
Celebrating Laurie Adami’s CAR T-cell anniversary
July 16 has more than one significance for Laurie Adami. It’s the date she met her future husband and the date cancer cell and gene therapy saved her life.
Read More
ACGT awards grant to scientist for remote-controlled CAR T cells
Alliance for Cancer Gene Therapy (ACGT) has awarded a research grant to Crystal Mackall, MD (Stanford University), to develop a sophisticated CAR T-cell therapy that can overcome some of the roadblocks presented by solid tumors.
Read More
ACGT awards grant to scientist for remote-controlled CAR T cells
Alliance for Cancer Gene Therapy (ACGT) has awarded a research grant to Crystal Mackall, MD (Stanford University), to develop a sophisticated CAR T-cell therapy that can overcome some of the roadblocks presented by solid tumors.
Read More
